What is Pulmonx Corporation's cumulative cost basis?

Pulmonx Corporation (LUNG) reported cumulative cost basis of $8.93M in Q1 2026.

How has Pulmonx Corporation's cumulative cost basis changed year-over-year?

Pulmonx Corporation's cumulative cost basis increased by 1.1% year-over-year, from $8.83M to $8.93M.

What is the long-term trend for Pulmonx Corporation's cumulative cost basis?

Over 5 years (2020 to 2025), Pulmonx Corporation's cumulative cost basis has grown at a 22.3% compound annual growth rate (CAGR), from $3.25M to $8.87M.

Pulmonx Corporation LUNG Cumulative Cost Basis

Cumulative Cost Basis at other companies

Intuitive SurgicalISRG

——

Zevra Therapeutics, Inc.ZVRA

——

ResMedRMD

——

Merit Medical SystemsMMSI

——

Other financials

Income statement

See full

Revenue$20.6M-8.7%

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

See full

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

See full

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

See full

Market cap$54.91M-43.7%

Enterprise value$50.17M-39.2%

P/S0.6×-0.5×

Profitability

See full

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

See full

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulmonx Corporation's cumulative cost basis?: Pulmonx Corporation (LUNG) reported cumulative cost basis of $8.93M in Q1 2026.
How has Pulmonx Corporation's cumulative cost basis changed year-over-year?: Pulmonx Corporation's cumulative cost basis increased by 1.1% year-over-year, from $8.83M to $8.93M.
What is the long-term trend for Pulmonx Corporation's cumulative cost basis?: Over 5 years (2020 to 2025), Pulmonx Corporation's cumulative cost basis has grown at a 22.3% compound annual growth rate (CAGR), from $3.25M to $8.87M.